US › Healthcare

EDAP TMS S.A. (FOCL)

US · Healthcare · Medical Distribution

$4.09-0.97%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$13.2M

Revenue YoY

-27.5%

Net profit

$-14.5M

EPS

$-0.24

EPS estimate

$-0.20

Net margin

-109.7%

EPS came in at -0.24 against a street estimate of -0.20 — a miss of 20.0%.

Key statistics

Market cap

$198.3M

Forward P/E

38.9

P/B

17.22

Book value

$-0.09

EPS (TTM)

$-1.39

52-week high

$6.40

52-week low

$1.75

50-day MA

$4.57

200-day MA

$4.37

Beta

-0.05

Analyst view

Analysts rate EDAP TMS S.A. a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $8.80.

Shareholding

Insiders

5.11%

Institutions

31.33%

Largest institutional holders

Fund	Stake
Soleus Capital Management, L.P.	15.48%
Morgan Stanley - Brokerage Accounts	7.08%
FLAX POND CAPITAL, LLC	3.23%
Rock Springs Capital Management LP	2.94%
Bruce & Co Inc	0.93%
Parkman Healthcare Partners LLC	0.33%
Essex Investment Management Company, LLC	0.31%
OHE Financial Inc	0.29%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for EDAP TMS S.A. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.